Daily Hong Kong Stock Market News Briefing (March 6, Thursday)

Baidu (09888.HK): Issued HKD 10 billion in senior notes.

Xiehe New Energy (00182.HK): The equity generation in the first two months was 1,591.92 GWh.

China Power (02380.HK): The total consolidated electricity sales in January were approximately 9.9813 million MWh.

CIFI Holdings Group (00884.HK): The cumulative contract sales in the first two months were approximately HKD 3.42 billion.

J&T EXPRESS-W (01519.HK): Revenue growth of 15.9% for the full year 2024, with the group achieving positive net profit for the first time.

Greentown China (03900.HK): The cumulative total contract sales amount in the first two months was approximately HKD 24 billion, a year-on-year decrease of 3.61%.

Xinyi International (00732.HK): The cumulative comprehensive operating net income in the first two months was approximately HKD 2.346 billion, a year-on-year decrease of about 15.6%.

Sunac China (01918.HK): The cumulative contract sales in the first two months were approximately HKD 8.64 billion, a year-on-year increase of 33.13%.

WULING MOTORS (00305.HK): Expected annual net profit of approximately HKD 104 million, a year-on-year increase of about 50%.

Ping An Insurance (Group) Company of China, Ltd. increased its holdings in Agricultural Bank (01288.HK) by 72.106 million shares, at a price of approximately HKD 4.72 per share.

Uni-President Enterprises China (00220.HK): Revenue of HKD 30.332 billion in 2024, an increase of 6.09%, with net profit of HKD 1.849 billion, a year-on-year increase of 10.92%.

Shanghai Pharmaceuticals Holding Co., Ltd. (01093.HK): The dual-functional fusion protein drug JMT108 has received clinical trial approval, indicated for advanced malignant tumors